The Risk Pharma Procurement Teams Are Not Pricing In

Why It Matters

The disruption raises drug costs, threatens patient access, and exposes procurement teams to financial and operational risk, making a data‑driven approach essential for resilience.

Key Takeaways

• Middle East conflict cut Gulf air cargo capacity by up to 80%.
• 10‑20% of global pharma trade routes through the Middle East.
• 56% of pharma firms still rely mainly on relationship‑driven procurement.
• Only 48% use market‑intelligence tools, leaving visibility gaps.

Pulse Analysis

The Middle East has long served as a logistical artery for the pharmaceutical industry, funneling 10‑20% of global drug shipments through its air and sea corridors. Recent hostilities have closed key airspace, prompting carriers to divert flights and lengthen maritime routes around the Red Sea and Strait of Hormuz. For cold‑chain freight, every extra hour translates into higher dwell time, increased risk of temperature excursions, and reduced shelf life, forcing manufacturers to write off or recondition valuable oncology and biologic products.

Pharma procurement has traditionally leaned on long‑standing relationships with freight forwarders, a model that 56% of firms still prioritize according to a 2026 Xeneta survey. While relationships provide regulatory compliance and reliability, they offer limited insight into real‑time market dynamics. The same study revealed that only 48% of organizations employ market‑intelligence tools, leaving a majority without visibility into shifting rates, capacity constraints, or emerging surcharges. This blind spot has already driven higher contingency budgets, last‑minute mode shifts, and a 35% incidence of stockouts or production delays across the sector.

The path forward lies in integrating real‑time freight intelligence with existing partnership frameworks. By layering data‑driven insights—such as spot‑rate fluctuations, carrier capacity alerts, and route risk scores—procurement teams can anticipate disruptions before they crystallize into cost spikes. Early adopters report faster decision cycles, reduced reliance on emergency spot purchases, and stronger supplier relationships built on shared transparency. As healthcare logistics investment is projected to exceed $140 billion, the competitive advantage will belong to firms that marry trusted relationships with actionable market data, turning volatility from a threat into a strategic lever.